Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

被引：0
|
作者：
Unger, Joseph M. [1 ]
Hershman, Dawn L. [2 ]
Osarogiagbon, Raymond U. [3 ]
Gothwal, Anirudh [4 ]
Anand, Seerat [5 ]
Dasari, Arvind [5 ]
Overnman, Michael [5 ]
Loree, Jonathan M. [6 ]
Raghav, Kanwal [5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Columbia Univ, New York, NY USA
[3] Baptist Canc Ctr, Memphis, TN USA
[4] Baylor Univ, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] BC Canc, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4344
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
    Unger, Joseph M.
    Hershman, Dawn L.
    Osarogiagbon, Raymond U.
    Gothwal, Anirudh
    Anand, Seerat
    Dasari, Arvind
    Overman, Michael
    Loree, Jonathan M.
    Raghav, Kanwal
    JNCI CANCER SPECTRUM, 2020, 4 (04)
  • [2] NATIONAL-CANCER-INSTITUTE SPONSORED COOPERATIVE CLINICAL-TRIALS
    FRIEDMAN, MA
    CAIN, DF
    CANCER, 1990, 65 (10) : 2376 - 2382
  • [3] Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials
    Nghiem, Van T.
    Vaidya, Riha
    Lyman, Gary H.
    Hershman, Dawn L.
    Ramsey, Scott D.
    Unger, Joseph M.
    VALUE IN HEALTH, 2020, 23 (12) : 1653 - 1661
  • [4] Cancer patient care in clinical trials sponsored by the National Cancer Institute: What does it cost?
    Brown, ML
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) : 818 - 819
  • [5] Incremental treatment costs in National Cancer Institute-sponsored clinical trials
    Goldman, DP
    Berry, SH
    McCabe, MS
    Kilgore, ML
    Potosky, AL
    Schoenbaum, ML
    Schonlau, M
    Weeks, JC
    Kaplan, R
    Escarce, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (22): : 2970 - 2977
  • [6] Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute sponsored clinical trials
    Christian, MC
    Trimble, EL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (03) : 277S - 283S
  • [7] Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
    Mittra, Arjun
    Naqash, Abdul Rafeh
    Murray, James H.
    Finnigan, Shanda
    Kwak-Kim, Joanne
    Ivy, S. Percy
    Chen, Alice P.
    Sharon, Elad
    ONCOLOGIST, 2021, 26 (10): : E1883 - E1886
  • [8] Analysis of cancer clinical trials in the United States with comparison of National Institute of Health (NIH) and pharmaceutical industry (PHARMA)-sponsored studies
    Oettel, K. R.
    Ruther, N. R.
    Mathiason, M. A.
    Keller, J. K.
    Schroeder, J. E.
    Go, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Trends in the National Cancer Institute (NCI) Sponsored Lung Cancer Clinical Trials Pre and Post NCI's National Clinical Trials Network (NCTN)
    Malik, S.
    Mishkin, G.
    Denicoff, A.
    Zhao, J.
    Korn, E.
    Mooney, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S359 - S360
  • [10] THE INSTITUTE OF MEDICINE, THE NATIONAL CANCER INSTITUTE, AND CLINICAL TRIALS
    Cox, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1285 - 1286
12345